RxDoctor Payments DataLook up a doctor →

Veita Bland, MD

Family Medicine · Greensboro, NCNPI 1083675433

Payments from drug & device makers

$107,660in general payments, 2019–2025

Across 693 payments — averaging $155.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Scientific Affairs, LLC$34K
  • AbbVie$27K
  • Sanofi US Services Inc.$20K
  • Bayer$11K
  • Idorsia Pharmaceuticals US Inc$2K
  • Amgen$2K
  • plus $11K from 49 others

What the payments were for

  • Consulting fees$36,30171%
  • Speaking & faculty fees$2,1004%
  • Travel & lodging$2,0724%
  • Food & beverage$10,62221%
  • Education$2080%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Scientific Affairs, LLC13$34,022
AbbVie(2 entities)47$27,497
Sanofi US Services Inc.5$20,302
Bayer38$10,501
Idorsia Pharmaceuticals US Inc1$2,100
Amgen10$1,882
AstraZeneca67$1,609
Otsuka Pharmaceutical Development & Commercialization, Inc.1$1,600
Novo Nordisk95$1,096
Lilly USA, LLC46$737
Boehringer Ingelheim36$642
Sanofi-aventis U.S. LLC38$589
Merck33$510
GSK27$433
Astellas Pharma US Inc15$375
Sunovion Pharmaceuticals Inc.26$372
Novartis21$353
Takeda Pharmaceuticals U.S.A., Inc.18$268
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$237
Esperion Therapeutics, Inc.13$210
Pfizer13$210
Amarin Pharma, Inc.15$209
Xeris Pharmaceuticals, Inc.9$162
Arbor Pharmaceuticals, Inc.9$162
Corcept Therapeutics8$159
Preventric Diagnostics, Inc.1$156
Johnson & Johnson11$155
Shield Therapeutics Inc7$105
Kowa Pharmaceuticals America, Inc.8$104
Mylan Specialty L.p.3$84
Medtronic(2 entities)5$78
Otsuka America Pharmaceutical, Inc.4$73
Abbott3$68
Sumitomo Pharma America, Inc.3$59
Biohaven Pharmaceutical Holding Company Ltd.3$59
Ironwood Pharmaceuticals, Inc3$43
Biohaven Pharmaceuticals, Inc.2$40
Viatris Specialty LLC1$38
Azurity Pharmaceuticals, Inc.2$36
Akcea Therapeutics, Inc.1$29
Avanir Pharmaceuticals, Inc.2$28
Lundbeck LLC1$25
Zyla Life Sciences, Inc.2$25
Global Blood Therapeutics, Inc.2$24
Actelion Pharmaceuticals US, Inc.1$23
Hologic Sales And Service, LLC1$21
Eisai Inc.1$21
Corium, LLC1$20
Dexcom, Inc.1$20
Ionis Pharmaceuticals, Inc.1$19
Aytu Biopharma, Inc.1$16
Inspire Medical Systems, Inc.1$16
Edwards Lifesciences1$15
Hikma Pharmaceuticals USA1$12
Medicure Pharma Inc.1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$107,660 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$43,633
Medicare patients
93
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide142$230,239
JardianceEmpagliflozin192$199,157
FarxigaDapagliflozin Propanediol111$105,606
Janumet XrSitagliptin Phos/Metformin Hcl80$69,014
JanuviaSitagliptin Phosphate58$56,951
RybelsusSemaglutide29$53,438
MounjaroTirzepatide27$44,118
EntrestoSacubitril/Valsartan44$37,541
GemtesaVibegron37$33,596
Breztri AerosphereBudesonide/Glycopyr/Formoterol53$33,554
XareltoRivaroxaban32$32,974
TrulicityDulaglutide24$31,817
KerendiaFinerenone21$22,377
JanumetSitagliptin Phos/Metformin Hcl33$21,477
LinzessLinaclotide31$19,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$1,096$287,885191 claims
Boehringer IngelheimJardiance, Synjardy Xr, Jentadueto, Tradjenta$642$235,050249 claims
MerckJanumet Xr, Januvia, Janumet, Steglatro$510$151,772183 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,609$143,246181 claims
Lilly USA, LLCMounjaro, Trulicity$737$75,93551 claims
Johnson & JohnsonXarelto, Invokana$155$47,22543 claims
NovartisEntresto$353$37,54144 claims
Sumitomo Pharma America, Inc.Gemtesa$59$33,59637 claims
AbbVieLinzess, Namzaric, Synthroid$27,497$33,17677 claims
BayerKerendia$10,501$22,37721 claims
PfizerEliquis$210$13,90318 claims
Esperion Therapeutics, Inc.Nexletol$210$13,01822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →